据报恒大(03333.HK)上周股价抽高前 对冲基金沽空比率大增
《彭博》报道,经过最近数月的减少押注後,对冲基金及其他沽空人士在上周再次对中国恒大(03333.HK)进行沽空狙击,於9月29日(上周二)加大沽空恒大股票比率近一倍,不过由於市场对公司现金紧张的忧虑减轻,该股翌日(30日)即上升了19%。
报道指,恒大早於2017年已斥数以十亿元资金作回购,对战狙击公司股票的沽空者,结果恒大当年股价大升458%,表现为485只恒生综合指数股份中最好。
另外,根据IHS Markit数据,公司本周一(8日)自由流通量的沽空比率高达18.5%,为去年4月以来最高,而沽空比率於2018年曾升至27%。恒大主席许家印持有公司流通股份逾70%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.